2Kamisago M,Sharma SD,Depalma SR,et al.Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy.N Engl J Med,2000,343:1688-1696.
3Olson TM,Kishimoto NY,Whitby FG,et al.Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy.J Mol Cell Cardiol,2001,33:723-732.
5Tsubata S,Bowles KR,Vatta M,et al.Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy.J Clin Invest,2000,106:655-662.
6Hack AA,Groh ME,McNally EM.Sarcoglycans in muscular dystrophy.Microsc Res Tech,2000,48:167-180.
7Daehmlow S,Erdmann J,Knueppel T,et al.Novel mutations in sarcomeric protein genes in dilated cardiomyopathy.Biochem Biophys Res Commun,2002,298:116.
8Gupta P,Bilinska ZT,Sylvius N,et al.Genetic and ultrastructural studies indilated cardiomyopathy patients:a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption.Basic Res Cardiol,2010,105:365-377.
9van Berlo JH,deVoogt WG,van der Kooi A J,et al.Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations:do lamin A/C mutations portend a high risk of sudden death? J Mol Med,2005,83:79-83.
10Sjakste N,Sjakste T.Nuclear matrix proteins and hereditary diseases.Geneti-ka,2005,41:293-298.
3Arber S,Hunter JJ,Ross J Jr,et al.MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization,dilated cardiomyopathy,and heart failure.Cell,1997,88:393-403.
4Cohn RD,Durbeej M,Moore SA,et al.Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex.J Clin Invest,2001,107:R1-R7.
5Azevedo VM,Albanesi Filho FM,Santos MA,et al.The role of L-carnitine in nutritional status and echocardiographic parameters in idiopathic dilated cardiomyopathy in children.J Pediatr (Rio J),2005,81:368-372.
6Richardson P,McKenna W,Bristow M,et al.Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.Circulation,1996,93:841-842.
8Codd MB,Sugrue DD,Gersh BJ,et al.Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy.A population-based study in Olmsted County,Minnesota,1975-1984.Circulation,1989,80:564-572.
9Dalakas MC,Park KY,Semino-Mora C,et al.Desmin myopathy,a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene.N Engl J Med,2000,342:770-780.
10Muntoni F,Di Lenarda A,Porcu M,et al.Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy.Heart,1997,78:608-612.
1Fatkin D. Guidelines for the diagnosis and management of familial dilated cardiomy opathy.Heart Lung Cire, 2011,20(11) : 691-693.
2Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of CardiologyFoundatiordAmerican Heart Association Task Force on Practice Guidelines .JAm Coll Cardiol, 2013, 62(16) e147~e239.
